KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Shares Outstanding (Diluted Average): 2014-2025

Historic Shares Outstanding (Diluted Average) for Aurinia Pharmaceuticals (AUPH) over the last 6 years, with Sep 2025 value amounting to $139.0 million.

  • Aurinia Pharmaceuticals' Shares Outstanding (Diluted Average) fell 4.59% to $139.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $139.0 million, marking a year-over-year decrease of 4.59%. This contributed to the annual value of $146.2 million for FY2024, which is 2.07% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $139.0 million, which was down 0.88% from $140.2 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Shares Outstanding (Diluted Average) ranged from a high of $146.2 million in Q4 2024 and a low of $127.4 million during Q1 2021.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $143.1 million, with a median of $143.2 million in 2025.
  • In the last 5 years, Aurinia Pharmaceuticals' Shares Outstanding (Diluted Average) rose by 11.20% in 2022 and then decreased by 4.59% in 2025.
  • Aurinia Pharmaceuticals' Shares Outstanding (Diluted Average) (Quarterly) stood at $129.4 million in 2021, then rose by 9.70% to $141.9 million in 2022, then increased by 0.93% to $143.2 million in 2023, then increased by 2.07% to $146.2 million in 2024, then fell by 4.59% to $139.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $139.0 million for Q3 2025, versus $140.2 million for Q2 2025 and $143.2 million for Q1 2025.